Rpar Risk Parity ETF (RPAR) オプション

Your year of what? Realizing I've been 100% correct about this SCAM since Wednesday, February 22, 2023 when I called out Franky Poo Poo and sold at 12 cents? It's been 22 months since then and you bagholders who ridiculed me for being RIGHT are still chasing that carrot. This scam is down almost 90%

smx....................................https://stockcharts.com/h-sc/ui?s=SMX&p=W&b=5&g=0&id=p86431144783

$PSRU Overview:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175532337

$PSRU Updates / PRs Ahead

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175532335
--------------------------------------------------
N

$7.31

Interesting interview from June 2008 with Jason Westerfield about the world transition to a hydrogen economy.

https://www.google.com/search?q=sid+roth+its+supernatural+interview+with+Jason+about+a+hydrogen+economy&rlz=1CDGOYI_enUS1037US1037&oq=sid+roth+its+supernatural+interview+with+

From what I gather this is not a Miro scam*....................
So why are they so concerned? SMH! LOL!

8Who signed the letter?

Quiet over will we get some nice dips or just continuation. High growth stock 

$ILLR First-Mover Advantage
🚀 Market leader: This company’s early entry into an emerging industry gives it a significant edge. With a growing moat, it’s set to dominate its niche.

$ILLR First-Mover Advantage
🚀 Market leader: This company’s early entry into an emerging industry gives it a significant edge. With a growing moat, it’s set to dominate its niche.

I think we’ve turned the corner and will start seeing news on a regular basis now!

Blakamizant is the brand name? I was hoping for better. Maybe that's a mistaken use of blarcamesine.

https://www.investing.com/news/company-news/tscan-secures-30-million-through-warrant-sale-to-lynx1-93CH-3788868

$ILLR Entering the Growth Phase
📊 Scalable model: With proven demand and a repeatable sales process, this company is transitioning into its growth phase. Early movers could see massive returns as revenues scale.

$ILLR Entering the Growth Phase
📊 Scalable model: With proven demand and a repeatable sales process, this company is transitioning into its growth phase. Early movers could see massive returns as revenues scale.

12/31 is the last day for tax loss selling and I see many of the trades in my weaker shares going lower. I will watch in January as the bottom fishing maybe happening and raise their prices. Then I will see if the bounce fizzles I will sell some for tax losses for 2025.

"Germany Rejects Chinese Carbon Credits Amid Fraud Concerns..." ~ Blockchain For Energy
Nov 28, 2024
https://x.com/Blockchain4NRG/status/1862156537646518433
"...Germany's Federal Environment Agency (UBA) has rejected carbon credits from Chinese projects. The need for transpare

OH SHIT...AT 62 MY EYES ARE NOT LIKE THEY USE TO BE..YOU WILL GET THERE SOME DAY....AND WHY DO YOU CARE...AS ONE OF THE MAIN BASHERS...WHY WOULD YOU BE CONCERNED ABOUT MY CAPS...MAYBE YOU ARE A BAGHOLDER AND ARE UPSET AT GEORGE FOR STEALING YOUR MONEY!

Yes! 
Price predictions: $10 for January 20th release, $20 for confirmation of FHFA head, $30 for relisting.

To the moon!

ZCAR, there it goes maybe

This looks like its ready to test the 52 week high's very positive news again this morning... on the footsteps of the Dec 23 clinical study results

https://www.otcmarkets.com/stock/RDGL/news/Vivos-Incs-IsoPet-Division-Achieves-Exceptional-Growth-in-2024-Expanding-Certified-Veterinary

$7.10

NEWS -- Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

https://media.zenfs.com/en/globenewswire.com/596a9a524bfac144adaabea16328ae5b

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB:

Most info i found in todays [Correction of statement]Semi-annual Report is just a lot of previuos company info and financial info but some info is interesting like this entry .

024.02.14 Conclusion of a single sales/supply contract. KIB has some good clientele

(Correc

From the NWBO patent application.

In one embodiment, t he hyperactive mature dendritic cells produced by any of the above methods are used for producing a medicament for treating cancer, particularly a solid tumor, a bacterial infection, or a viral infection.
Inventor Marnix L

you SHOULD TAKE your OWN ADVICE!!!